VT News
Akbar Hashemi Rafsanjani

Akbar Hashemi Rafsanjani

Ask VT AI
View News Summary
  • Novartis is in advanced talks to acquire U.S. biotech Avidity Biosciences for over $12 billion, bolstering its neuroscience and RNA strategy.
  • LSU officials in high-level discussions about Brian Kelly's future after a blowout loss to Texas A&M, with a potential buyout complicating matters.
  • Teenage Saracens winger Noah Caluori earns surprise England call-up after impressive Premiership debut.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis is in advanced talks to acquire U.S. biotech Avidity Biosciences for over $12 billion, bolstering its neuroscience and RNA strategy.
  • LSU officials in high-level discussions about Brian Kelly's future after a blowout loss to Texas A&M, with a potential buyout complicating matters.
  • Teenage Saracens winger Noah Caluori earns surprise England call-up after impressive Premiership debut.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Akbar Hashemi Rafsanjani

Top Topics

Trending in U.S.

World

Sport